SR

Smruti Rekha Priyadarshini

Active Director Director DIN 07835845
DIN 07835845 First appointment May 2017 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Smruti Rekha Priyadarshini

Data last updated:

Smruti Rekha Priyadarshini is a Director at Astacus Health Care Private Limited (since 2017). The company operates in Chemicals.

DIN 07835845
Primary Designation Director
Industry Chemicals
First Appointment 20 May 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astacus Health Care Private Limited U24239OR2017PTC026829
Director20 May 20172017Active

Board colleagues of Smruti Rekha Priyadarshini

NameDINCompanyDesignation
Raja Kishore Nathsharma07720292Astacus Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Astacus Health Care Private Limited
Premium access

Shareholding and investment profile for Smruti Rekha Priyadarshini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smruti Rekha Priyadarshini

Smruti Rekha Priyadarshini currently holds 1 directorship: Astacus Health Care Private Limited (Director, since 20 May 2017).

Smruti Rekha Priyadarshini was first appointed on 20 May 2017 as Director at Astacus Health Care Private Limited.

The current boards of Smruti Rekha Priyadarshini's companies include Raja Kishore Nathsharma (Astacus Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available